Your browser doesn't support javascript.
loading
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.
Kaufmann, Stefan H E; Dockrell, Hazel M; Drager, Nick; Ho, Mei Mei; McShane, Helen; Neyrolles, Olivier; Ottenhoff, Tom H M; Patel, Brij; Roordink, Danielle; Spertini, François; Stenger, Steffen; Thole, Jelle; Verreck, Frank A W; Williams, Ann.
Affiliation
  • Kaufmann SHE; Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
  • Dockrell HM; Immunology and Infection Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Drager N; Tuberculosis Vaccine Initiative (TBVI), Lelystad, Netherlands.
  • Ho MM; Bacteriology Division, MHRA-NIBSC, Potters Bar, United Kingdom.
  • McShane H; University of Oxford, Oxford, United Kingdom.
  • Neyrolles O; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
  • Ottenhoff THM; Leiden University Medical Center, Leiden, Netherlands.
  • Patel B; RegExcel Consulting Ltd, Surrey, United Kingdom.
  • Roordink D; Tuberculosis Vaccine Initiative (TBVI), Lelystad, Netherlands.
  • Spertini F; Centre Hospital Universitaire Vaudois, Lausanne, Switzerland.
  • Stenger S; University Hospital of Ulm, Ulm, Germany.
  • Thole J; Tuberculosis Vaccine Initiative (TBVI), Lelystad, Netherlands.
  • Verreck FAW; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Williams A; Public Health England, London, United Kingdom.
Front Immunol ; 8: 1203, 2017.
Article in En | MEDLINE | ID: mdl-29046674

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Immunol Year: 2017 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Immunol Year: 2017 Document type: Article Affiliation country: Germany Country of publication: Switzerland